Annemarie Mohring

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Allogeneic Transplantation in the Rare Disease Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Neutrophilia: Age and Disease Burden Determine Outcome.

Allogeneic Transplantation in the Rare Disease Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Neutrophilia: Age and Disease Burden Determine Outcome.

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome.

Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome.

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group.

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group.

Journal: Transplantation and cellular therapy

Published: September 10, 2025

Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission.

Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission.

Journal: Transplantation and cellular therapy

Published: August 20, 2025

Outcome after Treosulfan-based conditioning in a real-world MDS cohort.

Outcome after Treosulfan-based conditioning in a real-world MDS cohort.

Journal: Bone marrow transplantation

Published: June 23, 2025

Cancer patients in the emergency department

Cancer patients in the emergency department

Journal: Medizinische Klinik, Intensivmedizin und Notfallmedizin

Published: March 03, 2023

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.

Journal: Cancers

Published: March 08, 2022

18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?

18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?

Journal: BMC medical imaging

Published: November 21, 2021

Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure.

Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure.

Journal: Frontiers in immunology

Published: February 03, 2021

Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.

Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.

Journal: Journal of molecular and cellular cardiology

Published: June 03, 2017

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.

Journal: JACC. Cardiovascular interventions

Published: May 31, 2017

Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin.

Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin.

Journal: Pharmacology

Published: April 20, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026